RIUZZI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.371
EU - Europa 1.862
AS - Asia 528
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
SA - Sud America 1
Totale 4.767
Nazione #
US - Stati Uniti d'America 2.364
UA - Ucraina 460
IE - Irlanda 432
IT - Italia 313
HK - Hong Kong 239
SE - Svezia 165
CN - Cina 113
FI - Finlandia 97
VN - Vietnam 94
DE - Germania 87
RU - Federazione Russa 74
GB - Regno Unito 61
RO - Romania 49
AT - Austria 35
BE - Belgio 18
CH - Svizzera 17
FR - Francia 17
KR - Corea 16
PL - Polonia 13
PH - Filippine 12
TR - Turchia 12
SG - Singapore 11
LB - Libano 9
NL - Olanda 6
GR - Grecia 5
TH - Thailandia 5
UZ - Uzbekistan 5
CA - Canada 4
CZ - Repubblica Ceca 4
EU - Europa 3
JP - Giappone 3
MX - Messico 3
BG - Bulgaria 2
IN - India 2
IQ - Iraq 2
IR - Iran 2
MD - Moldavia 2
AF - Afghanistan, Repubblica islamica di 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
IL - Israele 1
LT - Lituania 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
TW - Taiwan 1
Totale 4.767
Città #
Chandler 543
Dublin 429
Jacksonville 254
Hong Kong 238
San Mateo 228
Perugia 108
Medford 107
Wilmington 107
Princeton 106
Dong Ket 94
Ann Arbor 89
Altamura 73
Andover 59
Lawrence 49
Beijing 47
Bucharest 46
Des Moines 45
Falls Church 33
Ashburn 32
Dearborn 32
Norwalk 28
Saint Petersburg 25
Vienna 25
Redmond 24
Shanghai 22
Brussels 18
Woodbridge 18
Helsinki 15
Los Angeles 15
Boardman 13
Izmir 11
Redwood City 11
New York 10
Philadelphia 9
Cebu City 7
Seodaemun-gu 7
Auburn Hills 6
Collazzone 6
Glasgow 6
Houston 6
Edinburgh 5
Milan 4
Nanjing 4
Renton 4
Seoul 4
Simi Valley 4
Xiamen 4
Chicago 3
Den Haag 3
Dumaguete 3
Guangzhou 3
Kunming 3
Moscow 3
Rimini 3
Siena 3
Singapore 3
Timisoara 3
Amsterdam 2
Aquila 2
Bangkok 2
Cannara 2
Chicoutimi 2
Chisinau 2
Ealing 2
Frankfurt Am Main 2
Jinan 2
Karaj 2
Lausanne 2
Monreale 2
Montreal 2
North Charleston 2
Oneonta 2
Piemonte 2
Prague 2
Raisio 2
Rome 2
San Daniele del Friuli 2
San Paolo di Civitate 2
Seongnam-si 2
Sindelfingen 2
Stockholm 2
Turin 2
Turku 2
Urbino 2
Villeurbanne 2
Abidjan 1
Athens 1
Atlanta 1
Baltimore 1
Bergen 1
Bologna 1
Central 1
Changsha 1
Città Di Castello 1
Clearwater 1
Copenhagen 1
Delhi 1
Falkenstein 1
Fossato Di Vico 1
Groningen 1
Totale 3.131
Nome #
RAGE signalling in myoblasts and embryonal rhabdomyosarcoma cells represses Pax7 expression via p38 MAPK-dependent induction of myogenin. 89
RAGE in the pathophysiology of skeletal muscle. 88
RAGE expression in rhabdomyosarcoma cells results in reduced proliferation, migration, and invasiveness in vitro and tumor growth in vivo 81
Activation of RAGE in myoblasts and rhabdomyosarcoma cells results in downregulation of Pax7 expression 79
An HMGB1/RAGE/p38 MAPK/Myogenin Axis Modulates Pax7 Expression in Myoblasts by Both Transcriptional and Post-Transcriptional Mechanisms 79
Oxidative stress-induced S100B accumulation converts myoblasts into brown adipocytes via an NF-κB/YY1/miR-133 axis and NF-κB/YY1/BMP-7 axis 76
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 74
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 74
Implication of RAGE and Amphoterin in Myogenesis 73
Amphoterin-induced myogenic differentiation of RAGE-transfected rhabdomyosarcoma TE671 cells 72
Opposing regulatory roles of S100B and amphoterin in myogenic differentiation: RAGE-dependence of amphoterin stimulatory effects vs. RAGE-independence of S100B inhibitory effects 70
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control 70
RAGE-independence of S100B inhibition of myogenic differentiation and myotube formation 68
Amphoterin stimulates myogenesis and counteracts the anti-myogenic factors, bFGF and S100B, via RAGE binding 66
Differential expression of S100B protein and RAGE in young and aged human satellite cells. 65
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 65
Cellular and molecular mechanisms of sarcopenia: the S100B perspective 64
Aged vs young human satellite cells: altered expression of S100B and RAGE, and defective ability in conditioning the medium contribute to impaired myogenic potential. 63
RAGE signaling in myoblasts and rhabdomyosarcoma cells causes downregulation of Pax7 expression via p38 MAPK activation and upregulation of myogenin expression 62
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation 62
RAGE engagement in myoblasts modulates proliferation, apoptosis, adhesiveness, migration and invasiveness 61
Molecular mechanism of S100B-dependent inhibition of myoblast differentiation 61
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 61
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 60
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 60
Effects of deletion of RAGE in muscle regeneration: preliminary observations. 59
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 57
Elucidating the mechanism of S100B-dependent regulation of myoblast differentiation. 55
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 55
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 54
The receptor RAGE: a potential molecular target in cancer cachexia 53
S100B causes apoptosis in myoblasts and inhibits myogenic differentiation and myotube formation in a RAGE-independent manner 52
S100B protein differentially regulates myoblast differentiation via direct binding to RAGE and bFGF-mediated activation of FGFR1 in low-density and high-density cultures, respectively 52
Potential role of S100B protein in myogenesis and skeletal muscle regeneration 51
Effects of RAGE expression in rhabdomyosarcoma cells 50
Mechanism of S100B-dependent inhibition of myoblast differentiation 50
Functional inactivation of RAGE in myoblasts results in tumor formation 50
S100B activates muscle satellite cells via RAGE engagement 50
Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis 50
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 50
Differential involvement of RAGE and FGFR1 in S100B effects on myoblast differentiation 49
HMGB1/RAGE modulates Pax7 expression in myoblasts via p38 MAPK-dependent upregulation of myogenin. 49
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 48
Functions of S100 proteins 47
S100B-dependent inhibition of myoblast differentiation: molecular mechanism 46
Complex regulatory effects of extracellular S100B on myoblast differentiation: S100B activates quiescent myoblats and satellite cells 46
Young and Aged Human Muscle Satellite Cells Show Differential Expression of S100B Protein and RAGE. 46
Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma 46
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 46
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 46
RAGE transduces antiproliferative, pro-apoptotic and anti-tumor signals in myoblasts 45
S100B protein accelerates the activation of quiescent myoblasts and muscle satellite cells. 45
Different intrinsic properties of young and aged human satellite cells. 45
Appropriate levels of extracellular S100B protein in injured muscle are required for correct muscle regeneration. 45
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 45
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 45
S100B activates quiescent myoblasts and satellite cells 43
Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. 42
Enforced expression of RAGE in rhabdomyosarcoma cells result in reduced proliferation, migration, and invasiveness in vitro, activation of a myogenic program, and reduced tumor growth in vivo. 42
RAGE modulates myoblast proliferation, apoptosis, migration and invasiveness 41
The many faces of S100B protein: when an extracellular factor inactivates its own receptor and activates another one. 41
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 41
S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond 40
Delayed Muscle Regeneration in RAGE-/- Skeletal Muscles. 40
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 40
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration 39
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 39
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 39
S100B inhibits myoblast differentiation via activation of a Ras-MEK-ERK1/2 signaling pathway 39
RAGE in tissue homeostasis, repair and regeneration. 38
Natural products to counteract muscle atrophy 38
S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner 37
S100 proteins in obesity: liaisons dangereuses 37
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 37
S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner 36
Reductive stress in striated muscle cells 36
S100B's double life: Intracellular regulator and extracellular signal. 35
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 35
Spatiotemporal regulation of Toll-like receptors and RAGE signaling pathways by S100B protein restrains inflammation 35
The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo 34
Role of CD45 signaling pathway in Galactoxylomannan-induced T cell damage. 34
Re-expression of RAGE in damaged skeletal muscles: RAGE-/- mice show delayed muscle regeneration 34
HMGB1/RAGE regulates muscle satellite cell homeostasis via p38 MAPK/myogenin dependent repression of Pax7 transcription 34
Differential engagement of RAGE and FGFR1 in muscle satellite cells by S100B protein: involvement of RAGE in satellite cell activation and of FGFR1 on satellite cell expansion. 34
S100B protein in tissue development, repair and regeneration 34
Causes of elevated serum levels of S100B protein in athletes 34
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 34
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 34
RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth 33
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 33
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 33
Regulatory effects of S100B protein on myoblast and muscle satellite cell differentiation depend on cell density and the time of exposure 32
S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner 32
Caveolins and cavins in muscle-derived tumours. 32
S100B protein restrains inflammation via spatiotemporal regulation of pathogen- and danger-sensing signaling pathways. 31
RAGE is re-expressed in skeletal muscle satellite cells after muscle injury and deletion of RAGE results in delayed muscle regeneration 29
S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK 28
RAGE-/- muscles show a high abundance of satellite cells but delayed muscle regeneration. 28
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA 28
S100B protein in skeletal muscle regeneration: regulation of myoblast and macrophage functions 28
Totale 4.833
Categoria #
all - tutte 17.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 26 7
2019/2020491 5 8 68 2 70 29 92 6 120 39 7 45
2020/2021887 2 69 31 73 284 46 81 6 91 18 75 111
2021/2022938 7 168 26 43 33 20 16 264 19 44 110 188
2022/20231.620 134 273 28 131 133 184 2 76 571 4 60 24
2023/2024558 43 70 29 31 15 18 211 23 80 16 22 0
Totale 4.989